Common pain syndromes in stroke patients: Review of two cases

Topics in Stroke Rehabilitation

Volumn 17, Issue 3, 2010, Pages 179-182

  Edgley, Steven ^a,b   Gershkoff, Arthur ^c,d  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Moss Rehab Hospital   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

hemiplegia; hip pain; shoulder pain; stroke rehabilitation

Indexed keywords

BOTULINUM TOXIN; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; SPASMOLYTIC AGENT; TRIAMCINOLONE;

ACROMION; ADULT; BURSITIS; CASE REPORT; CLINICAL FEATURE; FEMALE; HIP PAIN; HUMAN; MALE; MUSCLE HYPERTONIA; PHYSICAL MEDICINE; REVIEW; SHOULDER PAIN; STROKE; SYNDROME DELINEATION; TRANSCUTANEOUS NERVE STIMULATION; AGED; ANALGESIA; CEREBROVASCULAR ACCIDENT; COMPLICATION; HIP; MIDDLE AGED; PAIN; PATHOLOGY; PATHOPHYSIOLOGY; SHOULDER;

AGED; FEMALE; HIP; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MANAGEMENT; SHOULDER; STROKE;

EID: 77956255388     PISSN: 10749357     EISSN: None     Source Type: Journal    
DOI: 10.1310/tsr1703-179     Document Type: Review

References (14)

1. Turner-Stokes L, Jackson D. Shoulder pain after stroke: a review of the evidence base to inform the development of an integrated care pathway. Clin Rehabil. 2002;16:276-298.
2. Chae J, Mascarenhas D, Yu DT, et al. Poststroke shoulder pain: its relationship to motor impairment, activity limitation, and quality of life. Arch Phys Med Rehabil. 2007;88:298-301.
3. Lindgren I, Jonsson AC, Norrving B, et al. Shoulder pain after stroke: a prospective population-based study. Stroke. 2007;38:343-348.
4. Lo S-F, Chen S-Y, Lin H-C, Jim Y-F, Meng N-H, Kao M-J. Arthrographic and clinical fi ndings in patients with hemiplegic shoulder pain. Arch Phys Med Rehabil. 2003;84:1786-1791.
5. Yelnik AP, Colle FM, Bonan IV, Vicaut E. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapularis muscle: a randomized double-blind placebo-controlled study of botulinum toxin A. J Neurol Neurosurg Psychiatry. 2007;78:845-848.
6. Lim JY, Koh JH, Paik NJ. Intramuscular botulinum toxin A reduces hemiplegic shoulder pain: a randomized double-blind comparative study versus intraarticular triamcinolone acetonide. Stroke. 2008;39(1):126-131.
7. Chae J, Wolf-Johnson T, Govil H. Subacromion corticosteroid injection for post-stroke shoulder pain: a retrospective chart review. Arch Phys Med Rehabil. 2007;88:1690-1693.
8. Chae J, Jedlicka L. Subacromial corticosteroid injection for poststroke shoulder pain: an exploratory prospective case series. Arch Phys Med Rehabil. 2009;90:501-506.
9. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-158.
10. Lakse E, Gunduz B, Erhan B, Celik EC: The effect of local injections in hemiplegic shoulder pain: a prospective, randomized, controlled study. Am J Phys Med Rehabil. 2009;88:805-814.
11. Birrell F, Croft P, Cooper C, Hosie G, Macfarlane G, Silman A; PCR Hip Study Group. Predicting radiographic hip osteoarthritis from range of movement. Rheumatology (Oxf). 2001;40:506-512.
12. Segal NA, Felson DT, Torner JC, Zhu Y, Curtis JR, Niu J, et al. Greater trochanteric pain syndrome: epidemiology and associated factors. Arch Phys Med Rehabil. 2007;88(8):988-992.
13. Williams BS, Cohen SP. Greater trochanteric pain syndrome: a review of anamoty, diagnosis and treatment. Anesthesia Analgesia. 2009;108(5): 1662-1670.
14. Cohen SP, Strassels SA, Foster L, Marvel J, Williams K, Crooks M, et al. Comparison of fl uoroscopically guided and blind corticosteroid injections for greater trochanteric pain syndrome: multicentre randomized controlled trial. Br Med J. 2009;338:b1088.